General Information
Version
1.1.0
Revision date
2016-09-20
Product name
CORPHEDRA (ephedrine sulfate injection, USP), 50 mg/mL, for intravenous injection
Product Synonyms
1-Phenyl-2-methylamine-propanol-1-sulfate; (-)-erythro-1-Hydroxy-2- 1-Phenyl-2-methylamine-propanol-1-sulfate; (-)-erythro-1-Hydroxy-2- (methylamino)-1-phenylpropane sulfate
Chemical name
Phenethylamine derivative
CAS No.
134-72-5
1.2.1 Relevant identified uses
Active pharmaceutical ingredient of the substance or mixture and uses
Emergency telephone
+1 (800) 424-9300, +1 (703) 527-3887
Icons in SDS
Company Information
company name
Par Sterile Products
e-mail address of the competent person responsible for the Safety Data Sheet
drugsafety@parpharm.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H302, H361d, H373
Hazard statements
Code
Statements
H302
Harmful if swallowed
H361d
Suspected of damaging the unborn child.
H373
May cause damage to organs through prolonged or repeated exposure
Section 2
SECTION 2: Hazards identification
2.1 Classification of the substance or mixture
. substance or mixture Globally Harmonized Specific Target Organ Toxicity (repeated exposure) - Category 2. Reproductive System [GHS] Toxicity - Category 2. Acute Toxicity (Oral) Category 4.
2.2 Label elements
SECTION 2 - HAZARDS IDENTIFICATION …continued
Signal word
Warning
Hazard statements
H302 - Harmful if swallowed. H361d - Suspected of damaging the unborn child. H373 - May cause damage to cardiovascular and central nervous systems through prolonged or repeated exposure. Rinse mouth. P405 - Store locked up. P501 - Dispose of contents/container to location in accordance with local/regional/national/international regulations. P202 - Do not handle until all safety precautions have been read and understood. P280 - Wear protective gloves/eye protection/face protection.
Precautionary statements
P308 + P313 - IF exposed or concerned: get medical advice/attention. P330 -
2.3 Other hazards
Ephedrine sulfate is a sympathetic nervous system activator. The recommended IV dose is 5-10 mg, up to 50 mg. The maximum recommended dose for a healthy adult is 100 mg in a 24-hour period for not more than 12 weeks. The most common adverse effects were observed in the cardiovascular system (high blood pressure, palpitations, increased heart rate, heart attacks, cardiac arrhythmia), the central nervous system (seizure, stroke, agitation, restlessness, anxiety, insomnia), and the gastrointestinal (GI) system (nausea, vomiting). Limited data suggests ephedrine may cause fetal heart defects when administered to pregnant women. Placental transfer is high (~70% of maternal blood levels), and it is also secreted in breast milk; single use has been linked to reduced breast milk production. Ephedrine has the potential to induce addiction following prolonged exposure; withdrawal symptoms may occur upon abrupt cessation. Note This substance meets criteria for classification under GHS as implemented by